Somaxon Pharmaceuticals, Inc. (SOMX) Reports In-Line Q1 Loss of 4c/Share

Somaxon Pharmaceuticals, Inc. (NASDAQ: SOMX) reported Q1 EPS of ($0.04), in-line with the analyst estimate of ($0.04). Revenue for the quarter came in at $2.74 million versus the consensus estimate of $3.31 million.

For earnings history and earnings-related data on Somaxon Pharmaceuticals, Inc. (SOMX) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Blue Owl leads $2.4 billion debt deal for Iren data center
• Warsh: Inflation Data Don’t Suggest Trend Meaningfully Improved
• BofA sees mixed signals for European software from US SaaS